Arnow, BA. Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization. J Clin Psychiatry
2004; 65 (suppl 12): 10–5.
Chapman, DP, Whitfield, CL, Felitti, VJ, Dube, SR, Edwards, VJ, Anda, RF. Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord
2004; 82: 217–25.
Mandelli, L, Serretti, A. Gene environment interaction studies in depression and suicidal behavior: an update. Neurosci Biobehav Rev
2013; 37: 2375–97.
Heils, A, Teufel, A, Petri, S, Stöber, G, Riederer, P, Bengel, D, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem
1996; 66: 2621–4.
Caspi, A, Sugden, K, Moffitt, TE, Taylor, A, Craig, IW, Harrington, H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science
2003; 301: 386–9.
Karg, K, Burmeister, M, Shedden, K, Sen, S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry
2011; 68: 444–54.
Wankerl, M, Wust, S, Otte, C. Current developments and controversies: does the serotonin transporter gene-linked polymorphic region (5-HTTLPR) modulate the association between stress and depression?
Curr Opin Psychiatry
2010; 23: 582–7.
Uher, R. Gene-environment interaction: overcoming methodological challenges. Novartis Found Symp
2008; 293: 13–26; .
Keller, MC. Gene × environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol Psychiatry
2014; 75: 18–24.
Gunn, JM, Gilchrist, GP, Chondros, P, Ramp, M, Hegarty, KL, Blashki, GA, et al. Who is identified when screening for depression is undertaken in general practice? Baseline findings from the diagnosis, management and outcomes of depression in primary care (diamond) longitudinal study. Med J Aust
2008; 188: S119–25.
Radloff, L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas
1977; 1: 385–401.
American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR (4th edn). APA
2000, xxxvii, 943 p.
Spitzer, RL, Kroenke, K, Williams, JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA
1999; 282: 1737–44.
Kroenke, K, Spitzer, RL, Williams, JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med
2001; 16: 606–13.
MacMillan, HL, Fleming, JE, Trocme, N, Boyle, MH, Wong, M, Racine, YA, et al. Prevalence of child physical and sexual abuse in the community. Results from the Ontario health supplement. JAMA
1997; 278: 131–5.
Straus, MA. The conflict tactics scales and its critics: an evaluation and new data on validity and reliability. In Physical Violence in American Families: Risk Factors and Adaptations to Violence in 8,145 Families (eds Straus, MA, Gelles, RJ): 29–73. Transaction Publishers, 1990.
Bagley, C. Prevalence and correlates of unwanted sexual acts in childhood in a national Canadian sample. Can J Public Health
1989; 80: 295–6.
Ware, J Jr, Kosinski, M, Keller, SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care
1996; 34: 220–33.
World Health Organization. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med
1998; 46: 1569–85.
World Health Organization. Composite International Diagnostic Interview (CIDI-Auto).
2.1 edition. WHO, 1997.
Norbeck, JS. Modification of life event questionnaires for use with female respondents. Res Nurs Health
1984; 7: 61–71.
Enoch, MA, Shen, PH, Xu, K, Hodgkinson, C, Goldman, D. Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol
2006; 20: 19–26.
Gelernter, J, Kranzler, H, Coccaro, EF, Siever, LJ, New, AS. Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am J Psychiatry
1998; 155: 1332–8.
Wendland, JR, Martin, BJ, Kruse, MR, Lesch, KP, Murphy, DL. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry
2006; 11: 224–6.
Kraemer, HC, Blasey, CM. Centring in regression analyses: a strategy to prevent errors in statistical inference. Int J Methods Psychiatric Res
2004; 13: 141–51.
Keller, MC. Gene x environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol Psychiatry
2014; 75: 18–24.
West, BT, Welch, KB, Galecki, AT. Linear Mixed Models: A Practical Guide Using Statistical Software.
Chapman & Hall/CRC, 2007.
Labonte, B, Suderman, M, Maussion, G, Navaro, L, Yerko, V, Mahar, I. Genome-wide epigenetic regulation by early-life trauma. Arch Gen Psychiatry
2012; 69: 722–31.
Belsky, J, Jonassaint, C, Pluess, M, Brummett, B, Williams, R. Vulnerability genes or plasticity genes?
2009; 14: 746–54.
Eley, TC, Sugden, K, Corsico, A, Gregory, AM, Sham, P, McGuffin, P, et al. Geneenvironment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry
2004; 9: 908–15.
Wilhelm, K, Mitchell, PB, Niven, H, Finch, A, Wedgwood, L, Scimone, A, et al. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry
2006; 188: 210–5.
Eley, TC, Hudson, JL, Creswell, C, Tropeano, M, Lester, KJ, Cooper, P, et al. Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol Psychiatry
2012; 17: 236–7.
Bockting, CL, Mocking, RJ, Lok, A, Koeter, MW, Schene, AH. Therapygenetics: the 5HTTLPR as a biomarker for response to psychological therapy?
2013; 18: 744–5.
Porcelli, S, Fabbri, C, Serretti, A. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur Neuropsychopharmacol
2012; 22: 239–58.
Uher, R, McGuffin, P. The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry
2008; 13: 131–46.
Vijayendran, M, Beach, SR, Plume, JM, Brody, GH, Philibert, RA. Effects of genotype and child abuse on DNA methylation and gene expression at the serotonin transporter. Front Psychiatry
2012; 3: 55.
Philibert, R, Madan, A, Andersen, A, Cadoret, R, Packer, H, Sandhu, H. Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. Am J Med Genet B Neuropsychiatric Genet
2007; 144B: 101–5.
Wankerl, M, Miller, R, Kirschbaum, C, Hennig, J, Stalder, T, Alexander, N. Effects of genetic and early environmental risk factors for depression on serotonin transporter expression and methylation profiles. Transl Psychiatry
2014; 4: e402.
Gelernter, J, Kranzler, H, Cubells, JF. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet
1997; 101: 243–6.
Spertus, IL, Yehuda, R, Wong, CM, Halligan, S, Seremetis, SV. Childhood emotional abuse and neglect as predictors of psychological and physical symptoms in women presenting to a primary care practice. Child Abuse Negl
2003; 27: 1247–58.
McKinney, CM, Harris, TR, Caetano, R. Reliability of self-reported childhood physical abuse by adults and factors predictive of inconsistent reporting. Violence Vict
2009; 24: 653–68.
Hardt, J, Rutter, M. Validity of adult retrospective reports of adverse childhood experiences: review of the evidence. J Child Psychol Psychiatry
2004; 45: 260–73.